Planned intervention: On Thursday March 28th 07:00 UTC Zenodo will be unavailable for up to 5 minutes to perform a database upgrade.
Published December 19, 2018 | Version v1
Dataset Open

Determining the nanoBRET AL2K IC50 values of 24 new ACVR1/ALK2 inhibitors

  • 1. Structural Genomics Consortium
  • 2. Bullock

Description

In an effort to develop clinical compounds for Diffused Intrinsic Pontine Glioma (DIPG) treatment, new analogues of ACVR1/ALK2 inhibitors are continuously synthesised by Ontario Institute for Cancer Research (OICR) and Charles River Laboratories (CRL). I will provide prompt feedback of the cellular assay results to guide their design of new compounds.

The blog post for this page can be found on the SGC opennotebook site:

https://openlabnotebooks.org/determining-the-nanobret-al2k-ic50-values-of-24-new-acvr1-alk2-inhibitors/

Files

Zenodo post012.pdf

Files (426.4 kB)

Name Size Download all
md5:85914125a886298215fbbf422d2d3212
426.4 kB Preview Download